Galera Therapeutics, Inc. (GRTXD) Capital expenditures 2018–2024
Galera Therapeutics, Inc. (GRTXD) annual capital expenditure history — cash spent on property, plant and equipment, per SEC filings.
$0FY2024 · since FY2018: $347,000 → $0
| Fiscal year | Value | YoY |
|---|---|---|
| FY2024 | $0 | -100.0% |
| FY2023 | $59,000 | +136.0% |
| FY2022 | $25,000 | -91.2% |
| FY2021 | $283,000 | -38.1% |
| FY2020 | $457,000 | -27.8% |
| FY2019 | $633,000 | +82.4% |
| FY2018 | $347,000 | — |
Capital expenditures are shown as the positive cash amount spent, as reported on the cash-flow statement.
Source: SEC XBRL filings · For reference only · Not investment advice